Drug Trial Radar · NCT06350032
Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jul 31, 2024
Primary completion
Nov 2028
Study completion Nov 2028
Sponsor
- Lead sponsor
- AOP Orphan Pharmaceuticals AGIndustry
- Sponsor type
- Industry
- First posted
- Apr 5, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate safety and tolerability of preservative-free parenteral treprostinil in paediatric patients with PAH (PH Group 1) who are below 18 years of age. The main question it aims to answer is: • if preservative-free parenteral treprostinil is safe and tolerable in the treatment of paediatric PAH in patients who are either prostacyclin-naïve or have been previously treated with commercially available parenteral treprostinil formulations. Participants will receive either subcutaneous (SC) or intravenous (IV) preservative-free treprostinil and will be observed for 5 months (20 weeks ± 1 week).
Conditions
- Pulmonary Arterial Hypertension
Interventions
preservative-free parenteral treprostinilDrug
Continuous infusion of either SC or IV preservative-free treprostinil. The dosing is not stipulated by the study protocol and will be done according to patient needs.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency and seriousness of adverse events and adverse drug reactionsTime frame: 5 months (20 weeks ± 1 weeks)
Locations
5 sites in 5 countries. Site status is shown where the registry gives one.
Medizinische Universität Wien
Vienna, State of Vienna, Austria · Recruiting
Necker-Enfants Malades Hospital, Paris
Paris, Paris, France · Recruiting
Gottsegen National Cardiovascular Center
Budapest, Budapest, Hungary · Recruiting
Pediatric Cardiac Center
Bratislava, Slovakia · Recruiting
Ramón y Cajal University Hospital
Madrid, Madrid, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.